1. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
2. Chapter 26. Privileged structures — An update
3. Chen, H.; Zhang, W.; Tam, R.; Raney, A. K. PCT Int. Appl. WO 2005058315 A1 20050630, 2005.
4. Mimicking dominant negative inhibition of prion replication through structure-based drug design
5. Levy, S. B.; Alekshun, M. N.; Podlogar, B. L.; Ohemeng, K.; Verma, A. K.; Warchol, T.; Bhatia, B.; Bowser, T.; Grier, M. U.S. Patent Appl., 2,005,124,678 A1 20,050,609, 2005.